Dow Up 0.59% Nasdaq Down 0.15%

Sunesis Pharmaceuticals, Inc. (SNSS)

-NasdaqCM
1.68 Down 0.01(0.53%) 9:48AM EDT - Nasdaq Real Time Price
Prev Close:1.69
Open:1.69
Bid:1.65 x 2900
Ask:1.69 x 1900
1y Target Est:1.96
Beta:2.57
Next Earnings Date:N/A
Day's Range:1.65 - 1.74
52wk Range:1.00 - 8.46
Volume:75,827
Avg Vol (3m):2,229,620
Market Cap:101.60M
P/E (ttm):N/A
EPS (ttm):-0.74
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SNSSDown 0.53%101.60M
AZNUp 0.80%91.06B
PFEUp 0.47%187.88B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):12.83
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.74
Quarterly EPS Est (Sep-14) :-0.17
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sunesis Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of oncology therapeutics for the treatment of solid and hematologic cancers. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback